No article in the knowledge graph for Wakamoto Pharmaceutical Co., Ltd. yet.
Who is Wakamoto Pharmaceutical Co., Ltd.?
Wakamoto Pharmaceutical Co., Ltd. is a Japanese pharmaceutical manufacturer focused on the research, development, manufacture, and supply of prescription and related pharmaceutical products for the Japanese healthcare market.
- Prescription pharmaceutical product development and supply
- Generic and branded drug manufacturing for Japanese healthcare providers
- Pharmaceutical quality control and regulatory compliance
- Drug formulation and manufacturing process management
- Distribution of pharmaceutical products through established domestic channels
Show more
More About
Within healthcare environments, pharmaceutical manufacturers such as Wakamoto Pharmaceutical operate within regulated supply chains that require documented quality management, batch traceability, and adherence to Japanese pharmaceutical regulations administered by the Ministry of Health, Labour and Welfare. Products are typically positioned for hospitals, clinics, pharmacies, and wholesale distributors that depend on consistent supply and verified product specifications.
The company's operations rest on established pharmaceutical technologies, including solid oral dosage formulation, sterile and non-sterile manufacturing processes, stability testing, and analytical methods such as chromatography used to confirm identity, purity, and potency. Quality systems generally follow Good Manufacturing Practice standards, which govern facility design, equipment qualification, documentation, and change control across the production lifecycle.
Comparisons to other manufacturers in the sector are most useful at the category level. Japanese generic drug suppliers and diversified pharmaceutical firms share similar business models, with revenue driven by prescription volume, price regulation under national insurance schedules, and the need to maintain reliable manufacturing capacity. Where Wakamoto differs in emphasis or product mix, those distinctions should be verified against current company disclosures.
The business significance of such offerings lies in their role within public health supply. Stable manufacturing, accurate labeling, and dependable distribution help maintain access to essential medicines, while compliance and pharmacovigilance functions support patient safety and regulatory reporting obligations.
In directory terms, the company is positioned within the pharmaceuticals segment of the health care sector, where its active product lines relate to prescription and generic drug manufacturing and supply. Its profile reflects a conventional pharmaceutical manufacturer serving domestic healthcare channels.
Our description of Wakamoto Pharmaceutical Co., Ltd.. Updated October 2026.